Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Review of Cardiovascular Therapy|July 20, 2023
Pregnancy in women with congenital heart disease: a focus on management and preventing the risk of complicationsGurleen Wander, Johanna A van der Zande, Roshni R Patel, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 19, 2023
Long-term quality of life after obstetric intensive care unit admission: A cross-sectional cohort studyKarishma P Ramlakhan, Johanna A van der Zande, Jolien W Roos-Hesselink, et al.
International Breastfeeding Journal|April 14, 2023
Maternal, fetal, neonatal and breastmilk flecainide concentration during maternal therapy and lactation: a case reportJohanna A van der Zande, Jérôme M J Cornette, Jolien W Roos-Hesselink, et al.
Research and Practice in Thrombosis and Haemostasis|July 10, 2025
Menstrual bleeding-specific quality of life in women on antiplatelet therapyEva K Kempers, Johanna A van der Zande, Paula M Janssen, et al.
Research and Practice in Thrombosis and Haemostasis|January 25, 2024
Effects of antiplatelet therapy on menstrual blood loss in reproductive-aged women: a systematic reviewEva K Kempers, Johanna A van der Zande, Paula M Janssen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 2, 2024
Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational studyLaura D P R van Maldegem, Johanna A van der Zande, Lucy A van Werkhoven, et al.
Heart Rhythm|May 24, 2025
The maternal exposure of digoxin and flecainide in relation to the safety and effectiveness in the treatment of non-hydropic fetal tachycardiaRosa M A Smeets, Ingrid M van Beynum, Charlotte van Kesteren, et al.
Heart (British Cardiac Society)|October 24, 2025
Twin pregnancies in women with heart disease are complicated by high risk of heart failure: data from the EORP ROPAC RegistryGurleen Wander, Johanna A van der Zande, Uğur Canpolat, et al.
The American Journal of Cardiology|August 9, 2024
ACE Inhibitor and Angiotensin Receptor Blocker Use During Pregnancy: Data From the ESC Registry Of Pregnancy and Cardiac Disease (ROPAC)Johanna A van der Zande, Karishma P Ramlakhan, Katja Prokselj, et al.
European Journal of Heart Failure|June 5, 2024
Diuretics in pregnancy: Data from the ESC Registry of Pregnancy and Cardiac disease (ROPAC)Johanna A van der Zande, Matthias Greutmann, Daniel Tobler, et al.
Pageof 2